JFL
BSX icon

Jarislowsky, Fraser Ltd’s Boston Scientific BSX Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$214M Sell
2,192,794
-76,179
-3% -$7.89M 1.18% 29
2025
Q2 		$244M Sell
2,268,973
-2,566
-0.1% -$260K 1.39% 24
2025
Q1 		$229M Sell
2,271,539
-247,733
-10% -$24.9M 1.44% 24
2024
Q4 		$223M Sell
2,519,272
-249,994
-9% -$22M 1.3% 30
2024
Q3 		$232M Sell
2,769,266
-109,947
-4% -$8.67M 1.3% 29
2024
Q2 		$222M Sell
2,879,213
-83,697
-3% -$6.13M 1.35% 30
2024
Q1 		$203M Sell
2,962,910
-65,305
-2% -$4.2M 1.16% 33
2023
Q4 		$175M Sell
3,028,215
-56,630
-2% -$3.02M 1.03% 33
2023
Q3 		$163M Sell
3,084,845
-46,273
-1% -$2.43M 1.06% 32
2023
Q2 		$169M Sell
3,131,118
-120,227
-4% -$6.28M 1.01% 33
2023
Q1 		$163M Sell
3,251,345
-627,195
-16% -$29.6M 1% 32
2022
Q4 		$179M Sell
3,878,540
-270,811
-7% -$11.7M 1.17% 27
2022
Q3 		$161M Buy
4,149,351
+923
+0% +$37K 1.11% 29
2022
Q2 		$155M Sell
4,148,428
-229,772
-5% -$9.35M 0.98% 30
2022
Q1 		$194M Sell
4,378,200
-55,074
-1% -$2.39M 1.03% 28
2021
Q4 		$188M Buy
4,433,274
+8,742
+0.2% +$367K 0.88% 33
2021
Q3 		$192M Sell
4,424,532
-79,147
-2% -$3.5M 0.93% 33
2021
Q2 		$193M Sell
4,503,679
-1,437
-0% -$60.5K 0.9% 33
2021
Q1 		$174M Buy
4,505,116
+92,249
+2% +$3.49M 0.86% 33
2020
Q4 		$159M Buy
4,412,867
+882,104
+25% +$31.8M 0.81% 35
2020
Q3 		$135M Buy
3,530,763
+472,383
+15% +$18.2M 0.79% 35
2020
Q2 		$107M Buy
3,058,380
+218,718
+8% +$7.88M 0.67% 39
2020
Q1 		$92.7M Buy
2,839,662
+706,782
+33% +$27.6M 0.67% 39
2019
Q4 		$96.4M Buy
2,132,880
+223,162
+12% +$9.34M 0.51% 42
2019
Q3 		$77.7M Buy
1,909,718
+556,875
+41% +$23.6M 0.44% 45
2019
Q2 		$58.1M Buy
+1,352,843
New +$52M 0.35% 51

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jarislowsky, Fraser Ltd's BSX Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd reduced its Boston Scientific (BSX) stake by 3.4% in Q3 2025, selling an estimated $7.89M and leaving 2,192,794 shares worth $214M. The position accounts for 1.18% of the portfolio, ranked #29.

Jarislowsky, Fraser Ltd first reported a position in BSX in Q2 2019 and has held it in 26 quarters since. The position peaked at $244M in Q2 2025. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Jarislowsky, Fraser Ltd held 2,192,794 shares of Boston Scientific worth $214M as of Q3 2025.
  • Jarislowsky, Fraser Ltd sold 76,179 Boston Scientific shares in Q3 2025, an estimated $7.89M.
  • Boston Scientific made up 1.18% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #29 holding.
  • Jarislowsky, Fraser Ltd first reported a position in Boston Scientific in Q2 2019 and has held it in 26 quarters since.
  • Jarislowsky, Fraser Ltd's Boston Scientific position peaked at $244M in Q2 2025.
  • 1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.